Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-08
2007-05-08
Seaman, Margaret D. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S471000, C549S273000, C549S292000, C549S321000
Reexamination Certificate
active
11261686
ABSTRACT:
Synthetic discodermolide analogs having utility as antiproliferative agents, having a structure represented by formula Awhere RAthrough REand XAare as defined herein.
REFERENCES:
patent: 4939168 (1990-07-01), Gunasekera
patent: 5789605 (1998-08-01), Smith, III
patent: 5840750 (1998-11-01), Longley
patent: 6031133 (2000-02-01), Smith, III
patent: 6096904 (2000-08-01), Smith, III
patent: 6127406 (2000-10-01), Gunasekera
patent: 6242616 (2001-06-01), Smith, III
patent: 6495594 (2002-12-01), Gunasekera et al.
patent: 6506910 (2003-01-01), Kinder, Jr.
patent: 6734177 (2004-05-01), Kinder, Jr.
patent: 2001/0049387 (2001-12-01), Gunasekera
patent: 2002/0103387 (2002-08-01), Smith, III
patent: 2003/0087934 (2003-05-01), Kinder, Jr.
patent: 2003/0153601 (2003-08-01), Kinder, Jr.
patent: 2004/0018598 (2004-01-01), Santi
patent: 2004/0048894 (2004-03-01), Smith, III
patent: 2004/0073049 (2004-04-01), Koch
patent: 2005/0049414 (2005-03-01), Smith, III
patent: 2005/0197369 (2005-09-01), Myles
patent: WO 02/12220 (2002-02-01), None
patent: WO 03/080567 (2003-10-01), None
Dermer et al., Bio/Technology,“Another anniversary for the war on cancer”, 1994, vol. 12, p. 320.
Freshney et al., Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York, P4.
Martelo et al., Chemistry & Biology, “The relationship between Taxol and (+)-discodermolide: sunthetic analogs and modeling studies”,2001, vol. 8, pp. 843-855.
Curran et al.,Org. Lett.4 (13), 2233-2235 (2002), “Simultaneous Preparation of Four Truncated Analogs of Discodermolide by Fluorous Mixture Synthesis”.
Gunasekera et al.,J. Nat. Prod.64 (2), 171-174 (2001), “Acetylated Analogues of the Microtubule Stabilizing Agent Discodermolide: Preparation and Biological Activity”.
Gunasekera et al.,J. Nat. Prod.65 (11), 1643-1648 (2002), “Five New Discodermolide Analogs from the Marine SpongeDiscodermiaSpecies”.
Gunasekera et al.,J. Nat. Prod.65 (12), 1830-1837 (2002), “Semisynthetic Analogues of the Microtubule Stabilizing Agent Discodermolide: Preparation and Biological Activity”.
Gunasekera et al.,J. Nat. Prod.67 (5), 749-756 (2004), “Synthetic Analogues of the Microtubule Stabilizing Agent (+)-Discodermolide: Preparation and Biological Activity”.
Harried et al.,J. Org. Chem., 62, 6098-6099 (1997), “Total Synthesis of (−)-Discodermolide: An Application of a Chelation-Controlled Alkylation Reaction”.
Harried et al.,J. Org. Chem., 68 (17), 6646-6660 (2003), “Total Synthesis of the Potent Microtubule-Stabilizing Agent (+)-Discodermolide”.
Hung et al.,J. Am. Chem. Soc., 118, 11054-11080 (1996), “Syntheses of Discodermolides Useful for Investigating Microtubule Binding and Stabilization”.
Marshall et al.,J. Org. Chem., 63, 7885-7892 (1998), “Total Synthesis of (+)-Discodermolide”.
Martello et al.,Chem. Biol.8, 843-855 (2001), The Relationship between Taxol and (+)-Discodermolide: Synthetic Analogs and Modeling Studies.
Mickel et al.,Org. Proc. Res. Dev.8 (1), 92-100 (2004), “Large-Scale Synthesis of the Anti-Cancer Marine Natural Product (+)-Discodermolide. Part 1: Synthetic Strategy and Preparation of a Common Precursor”.
Mickel et al.,Org. Proc. Res. Dev.8 (1), 101-106 (2004), “Large-Scale Synthesis of the Anti-Cancer Marine Natural Product (+)-Discodermolide. Part 2: Synthesis of Fragments C1-6and C9-14”.
Mickel et al.,Org. Proc. Res. Dev.8 (1), 107-112 (2004), “Large-Scale Synthesis of the Anti-Cancer Marine Natural Product (+)-Discodermolide. Part 3: Synthesis of Fragment C51-21”.
Mickel et al.,Org. Proc. Res. Dev.8 (1), 113-121 (2004), “Large-Scale Synthesis of the Anti-Cancer Marine Natural Product (+)-Discodermolide. Part 4: Preparation of Fragment C7-24”.
Mickel et al.,Org. Proc. Res. Dev.8 (1), 122-130 (2004), “Large-Scale Synthesis of the Anti-Cancer Marine Natural Product (+)-Discodermolide. Part 5: Linkage of Fragments C1-6and C7-24and Finale”.
Minguez et al.,Bioorg. Med. Chem.11 (15), 3335 (2003), “Synthesis and Biological Assessment of Simplified Analogues of the Potent Microtubule Stabilizer (+)-Discodermolide” (abstract).
Nerenberg et al.,J. Am. Chem. Soc.115, 12621-12622 (1993), “Total Synthesis of the Immunosuppressive Agent (−)-Discodermolide”.
Paterson et al.,Angew. Chem. Int. Ed., 39, 377-380 (2000), “Total Synthesis of the Antimicrotubule Agent (+)-Discodermolide Using Boron-Mediated Aldol Reactions of Chiral Ketones”.
Paterson et al.,Eur. J. Org. Chem., 12, 2193-2208 (2003), “The Development of a Practical Total Synthesis of Discodermolide, a Promising Microtubule-Stabilizing Anticancer Agent”.
Paterson et al.,J. Am. Chem. Soc., 123, 9535-9544 (2001), “A Practical Synthesis of (+)-Discodermolide and Analogues: Fragment Union by Complex Aldol Reactions”.
Paterson et al.,Org. Lett., 5, 35-38 (2003), “1,6-Asymmetric Induction in Boron-Mediated Aldol Reactions: Application to a Practical Total Synthesis of (+)-Discodermolide”.
Paterson et al.,Tetrahedron Lett., 41, 6935-6939 (2000), “Synthesis of (+)-discodermolide and analogues by control of asymmetric induction in aldol reactions of γ-chiral and (Z)-enals”.
Paterson et al.,Tetrahedron Lett., 44 (49), 8877 (2003), “Synthesis of Novel Discodermolide Analogues with Modified Hydrogen-Bonding Donor/Acceptor Sites” (abstract).
Smith, III et al.,J. Am. Chem. Soc., 112, 8654-8664 (2000), “Evolution of a Gram-Scale Synthesis of (+)-Discodermolide”.
Smith, III et al.,J. Am. Chem. Soc., 117, 12011-12012 (1995), “Total Synthesis of (−)-Discodermolide”.
Smith, III et al.,Org. Lett.5 (23), 4405-4408 (2003), “A Practical Improvement, Enhancing the Large-Scale Synthesis of (+)-Discodermolide: a Third-Generation Approach”.
Smith, III et al.,Org. Lett., 1, 1823-1826 (1999), “Gram-Scale Synthesis of (+)-Discodermolide” (additions and correctionsOrg. Lett.2, 1983 (2000).
Wermuth, “Designing Prodrugs and Bioprecursors,” in Wermuth, ed.,The Practice of Medicinal Chemistry, 2nd Ed., pp. 561-586 (Academic Press 2003).
He et al.,Drug Discovery Today2001, 6 (22), 1153-1164, “Novel molecules that interact with microtubules and have a functional activity similar to Taxol™”.
Paterson et al.,Org. Lett.2004, 6 (26), 4933-4936, Total Synthesis of (+)-Discodermolide: An Improved Endgame Exploiting a Still-Gennari-Type Olefination with a C1-C8 β-Ketophosphonate Fragment.
Santi Daniel V.
Shaw Simon James
Sundermann Kurt F.
Chao Yuan
Kosan Biosciences Incorporated
Rahmani Niloofar
Seaman Margaret D.
LandOfFree
Synthetic discodermolide analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic discodermolide analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic discodermolide analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3791822